Source:http://linkedlifedata.com/resource/pubmed/id/11369032
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-5-22
|
pubmed:abstractText |
Acidic extracellular pH reduced high-voltage-activated (HVA) currents in freshly isolated cortical pyramidal neurones of adult rats, shifting activation to more positive voltages (V(1/2)=-18 mV at pH 7.4, -11 mV at pH 6.4). Sipatrigine inhibited HVA currents, with decreasing potency at acidic pH (IC(50) 8 microM at pH 7.4, 19 microM at pH 6.4) but the degree of maximal inhibition was >80% in all cases (pH 6.4-8.0). Sipatrigine has two basic groups (pK(A) values 4.2, 7.7) and at pH 7.4 is 68% in monovalent cationic form and 32% uncharged. From simple binding theory, the pH dependence of sipatrigine inhibition indicates a protonated group with pK(A) 6.6. Sipatrigine (50 microM) shifted the voltage dependence of channel activation at pH 7.4 (-7.6 mV shift) but not at pH 6.4. Lamotrigine has one basic site (pK(A) 5.5) and inhibited 34% of the HVA current, with similar potency over the pH range 6.4--7.4 (IC(50) 7.5--9 microM). These data suggest that the sipatrigine binding site on HVA calcium channels binds both cationic and neutral forms of sipatrigine, interacts with a group with pK(A)=6.6 and with the channel activation process, and differs from that for lamotrigine.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Neurotransmitter Uptake Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Triazines,
http://linkedlifedata.com/resource/pubmed/chemical/lamotrigine,
http://linkedlifedata.com/resource/pubmed/chemical/sipatrigine
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0028-3908
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
784-91
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11369032-Animals,
pubmed-meshheading:11369032-Calcium Channel Blockers,
pubmed-meshheading:11369032-Calcium Channels,
pubmed-meshheading:11369032-Hydrogen-Ion Concentration,
pubmed-meshheading:11369032-Male,
pubmed-meshheading:11369032-Neocortex,
pubmed-meshheading:11369032-Neurons,
pubmed-meshheading:11369032-Neurotransmitter Uptake Inhibitors,
pubmed-meshheading:11369032-Piperazines,
pubmed-meshheading:11369032-Pyrimidines,
pubmed-meshheading:11369032-Rats,
pubmed-meshheading:11369032-Rats, Wistar,
pubmed-meshheading:11369032-Triazines
|
pubmed:year |
2001
|
pubmed:articleTitle |
Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-activated (HVA) calcium channels in dissociated neurones of rat cortex.
|
pubmed:affiliation |
Section of Pharmacology, School of Pharmacy, De Montfort University, Leicester LE1 9BH, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|